US Patent Issued to FUDAN UNIVERSITY, SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES, SHANGHAI MIRACOGEN on May 6 for "Tissue factor-targeted antibody-drug conjugate" (Chinese Inventors)

ALEXANDRIA, Va., June 10 -- United States Patent no. 12,290,505, issued on May 6, was assigned to FUDAN UNIVERSITY (Shanghai), SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (Shanghai) and SHANGHAI MIRACOGEN INC. (Shanghai).

"Tissue factor-targeted antibody-drug conjugate" was invented by Ke Yu (Shanghai), Jingkang Shen (Shanghai), Tao Meng (Shanghai), Lanping Ma (Shanghai), Xuesai Zhang (Shanghai), Qingrou Li (Shanghai) and Qing Lin (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "A tissue factor (TF)-targeted antibody-drug conjugate (ADC) and a method for preparing the ADC. The ADC is capable of binding to TF antigen with high specificity, and has high affinity, low immunogenicit...